Treatment of human pancreatic cancer in mice with angiogenic inhibitors

World Journal of Surgery

Volumn 27, Issue 4, 2003, Pages 405-411

  Prox, Daniela ^a   Becker, Christian ^a,b   Pirie Shepherd, Steven R ^a,c   Celik, Ilhan ^d   Folkman, Judah ^a,e   Kisker, Oliver ^a,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Attenuon LLC   (United States)

^d UNIVERSITY HOSPITAL MARBURG   (Germany)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIANGIOGENIC ANTITHROMBIN III; ENDOSTATIN; FUMAGILLOL CHLOROACETYLCARBAMATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ENDOTHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROVASCULATURE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PANCREAS CANCER; SCID MOUSE; TUMOR GROWTH;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTITHROMBIN III; APOPTOSIS; CELL DIVISION; COLLAGEN; CYCLOHEXANES; ENDOSTATINS; HUMANS; MICE; PANCREATIC NEOPLASMS; PEPTIDE FRAGMENTS; RNA; SESQUITERPENES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0043245876     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-002-6816-4     Document Type: Article

References (21)

1. Yeo CJ. Pancreatic cancer: 1998 update. J. Am. Coll. Surg. 1998;187:429-442
2. Pluda JM, Parkinson DR. Clinical implication of tumor-associated neovascularization and current antiangiogenic strategies for the treatment of malignancies of pancreas. Cancer 1996;78:680-687
3. O'Reilly M, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-328
4. Rastinejad F, Polverini PJ, Bouck NP. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 1989;56:345-355
5. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-364
6. Ingber D, Fujita T, Kishimoto S, et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 1990;348:555-557
7. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277-285
8. O'Reilly MS, Pirie-Shepherd S, Lane WS, et al. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science 1999;285:1926-1928
9. Sim BKL, Fogler WE, Zhou XH, et al. Zinc ligand-disrupted recombinant human endostatin: potent inhibition of tumor growth, safety and pharmacokinetic profile. Angiogenesis 1999;3:41-51
10. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med. 1995;1:149-152
11. O'Reilly MS, Holmgren L, Chen C, et al. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med. 1996;2:689-692
12. Yamanaka Y, Friess H, Buchler M, et al. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor state. Cancer Res. 1993;53:5289-5296
13. Itakura J, Ishiwata T, Friess H, et al. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin. Cancer Res. 1997;8:1309-1316
14. O'Mahony CA, Seidel A, Albo D, et al. Angiostatin generation by human pancreatic cancer. J. Surg. Res. 1998;77:55-58
15. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N. Engl. J. Med. 1991;324:1-8
16. Folkman J. New perspectives in clinical oncology from angiogenesis research. Eur. J. Cancer 1996;32A:2534-2539
17. Egawa S, Tsutsumi M, Konishi Y, et al. The role of angiogenesis in the tumor growth of syrian hamster pancreatic cancer cell line HPD-NP. Gastroenterology 1995;108:1526-1533
18. Yanagi K, Onda M, Uchida E. Effect of angiostatin on liver metastasis of pancreatic cancer in hamsters. Jpn. J. Cancer Res. 2000;91:723-730
19. Kawarada Y, Ishikura H, Kishimoto T. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vitro. Pancreas 1997;15:251-257
20. Shishido T, Yasoshima T, Denno R, et al. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin. Jpn. J. Cancer Res. 1998;89:963-969
21. Mauceri HJ, Hanna NN, Beckett MA, et al. Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature 1998;394:287-291